These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 7115640

  • 1. Cytoplasmic steroid receptors in ovarian tumours.
    Quinn MA, Pearce P, Rome R, Funder JW, Fortune D, Pepperell RJ.
    Br J Obstet Gynaecol; 1982 Sep; 89(9):754-9. PubMed ID: 7115640
    [Abstract] [Full Text] [Related]

  • 2. Oestrogen, progesterone, and androgen receptors in ovarian neoplasia: correlation between immunohistochemical and biochemical receptor analyses.
    van Doorn HC, Burger CW, van der Valk P, Bonfrèr HM.
    J Clin Pathol; 2000 Mar; 53(3):201-5. PubMed ID: 10823139
    [Abstract] [Full Text] [Related]

  • 3. Correlation between cytoplasmic steroid receptors and tumour differentiation and invasion in endometrial carcinoma.
    Quinn MA, Pearce P, Fortune DW, Koh SH, Hsieh C, Cauchi M.
    Br J Obstet Gynaecol; 1985 Apr; 92(4):399-406. PubMed ID: 3986169
    [Abstract] [Full Text] [Related]

  • 4. Clinical evaluation of steroid receptors in ovarian neoplasms.
    Agarwal N, Rao DL, Murgeshan K, Verma U, Mittal S, Buckshee K, Chapeker TN.
    Int J Gynaecol Obstet; 1987 Apr; 25(2):145-9. PubMed ID: 2884140
    [Abstract] [Full Text] [Related]

  • 5. [Cytoplasmatic receptors of steroid hormones in malignant epithelial ovarian tumors].
    Makhova EE, Gershteĭn ES, Smirnova KD, Murav'eva NI, Kuz'mina ZV.
    Vopr Onkol; 1984 Apr; 30(12):36-40. PubMed ID: 6516272
    [Abstract] [Full Text] [Related]

  • 6. Steroid receptors in human ovarian malignancy. A review of four years tissue collection.
    Toppila M, Tyler JP, Fay R, Baird PJ, Crandon AJ, Eastman CJ, Hudson CN.
    Br J Obstet Gynaecol; 1986 Sep; 93(9):986-92. PubMed ID: 3768292
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical characterization of mullerian mucinous borderline tumors: possible histogenetic link with serous borderline tumors and low-grade endometrioid tumors.
    Yasunaga M, Ohishi Y, Oda Y, Misumi M, Iwasa A, Kurihara S, Nishimura I, Okuma E, Kobayashi H, Wake N, Tsuneyoshi M.
    Hum Pathol; 2009 Jul; 40(7):965-74. PubMed ID: 19269675
    [Abstract] [Full Text] [Related]

  • 8. Clinical significance of estrogen and progestin receptors in ovarian cancer.
    Kauppila A, Vierikko P, Kivinen S, Stenbäck F, Vihko R.
    Obstet Gynecol; 1983 Mar; 61(3):320-6. PubMed ID: 6823373
    [Abstract] [Full Text] [Related]

  • 9. Oestrogen and progesterone receptor content as a prognostic factor in advanced epithelial ovarian carcinoma.
    Sevelda P, Denison U, Schemper M, Spona J, Vavra N, Salzer H.
    Br J Obstet Gynaecol; 1990 Aug; 97(8):706-12. PubMed ID: 2400748
    [Abstract] [Full Text] [Related]

  • 10. Estrogen and progesterone receptors in human ovarian tumors.
    Willcocks D, Toppila M, Hudson CN, Tyler JP, Baird PJ, Eastman CJ.
    Gynecol Oncol; 1983 Oct; 16(2):246-53. PubMed ID: 6313494
    [Abstract] [Full Text] [Related]

  • 11. Steroid receptor content in human ovarian tumors: survival of patients with ovarian carcinoma related to steroid receptor content.
    Iversen OE, Skaarland E, Utaaker E.
    Gynecol Oncol; 1986 Jan; 23(1):65-76. PubMed ID: 3943754
    [Abstract] [Full Text] [Related]

  • 12. Androgen receptors in ovarian tumors: correlation with oestrogen and progesterone receptors in an immunohistochemical and semiquantitative image analysis study.
    Cardillo MR, Petrangeli E, Aliotta N, Salvatori L, Ravenna L, Chang C, Castagna G.
    J Exp Clin Cancer Res; 1998 Jun; 17(2):231-7. PubMed ID: 9700586
    [Abstract] [Full Text] [Related]

  • 13. Hormonal activity of epithelial ovarian tumours in post-menopausal women.
    Heinonen PK, Mörsky P, Aine R, Koivula T, Pystynen P.
    Maturitas; 1988 Mar; 9(4):325-38. PubMed ID: 3380017
    [Abstract] [Full Text] [Related]

  • 14. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC, Lippman ME, Thompson EB, Simon R, Barlock A, Green L, Huff KK, Do HM, Aitken SC.
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Estrogen and progesterone receptors in ovarian neoplasms.
    Ford LC, Berek JS, Lagasse LD, Hacker NF, Heins Y, Esmailian F, Leuchter RS, DeLange RJ.
    Gynecol Oncol; 1983 Jun; 15(3):299-304. PubMed ID: 6862289
    [Abstract] [Full Text] [Related]

  • 18. [Estrogen and progesterone receptors in malignant ovarian neoplasms].
    Teufel G, Geyer H, de Gregorio G, Fuchs A, Kleine W, Pfleiderer A.
    Geburtshilfe Frauenheilkd; 1983 Dec; 43(12):732-40. PubMed ID: 6559148
    [Abstract] [Full Text] [Related]

  • 19. [Androgen receptors in primary breast carcinoma. Relation to prognostic factors in comparison with estrogen and progesterone receptors].
    Reiner G, Jakesz R, Kolb R, Kühnl-Brady K, Reiner A, Schemper M, Spona J.
    Dtsch Med Wochenschr; 1988 Jun 03; 113(22):892-7. PubMed ID: 3371221
    [Abstract] [Full Text] [Related]

  • 20. DNA profile and steroid receptor content of human ovarian cancer.
    Jakobsen A, Hansen V, Poulsen HS.
    Eur J Gynaecol Oncol; 1988 Jun 03; 9(6):461-3. PubMed ID: 3234424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.